Search

Home > GRACEcast Lung Cancer Video > ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients
Podcast: GRACEcast Lung Cancer Video
Episode:

ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients
Category: Science & Medicine
Duration: 00:03:10
Publish Date: 2015-10-29 20:52:31
Description:

Drs. Ben Solomon, Leora Horn, & Jack West review trial result and implications of ECOG 1505 trial that showed no benefit to addition of Avastin (bevacizumab) to adjuvant chemotherapy for early stage NSCLC.
Total Play: 0